
Keywords: ANOVA, analysis of variance; ARG1, arginase-1; ATR, ataxia telangiectasia mutated–Rad3-related protein; BAK, BCL2-antagonist/killer; BAX, BCL2-associted X protein; CASP3, caspase 3; CCND1, cyclin D1; CDC2, cell division control 2; CDC7, cell division cycl